Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology – disclosure of fundamental structural and metabolic relationships

Lipoprotein subclasses by NMR spectroscopy

The separation of lipoprotein subclasses in proton NMR spectroscopy is based on particle size. In more detail, the anisotropy of the magnetic susceptibility, due to the radially oriented surface monolayer of the spherical particles, inherently leads to a size-dependent frequency shift for the NMR resonances of lipoprotein lipids.¹⁶ The NMR data in this particular platform are calibrated via high-performance liquid chromatography with the platform resolution being 14 lipoprotein subclasses, defined by their particle size as follows: six very-low-density lipoprotein (VLDL) particle categories; extremely large (XXL-VLDL, with average particle diameter >75 nm), very large (XL-VLDL, 64 nm), large (L-VLDL, 53.6 nm), medium (M-VLDL, 44.5 nm), small (S-VLDL, 36.8 nm), and very small (XS-VLDL, 31.3 nm); intermediate-density lipoprotein particles (IDL, 28.6 nm), large (L-LDL, 25.5 nm), medium (M-LDL, 23.0 nm), and small LDL particles (S-LDL, 18.7 nm); and very large (XL-HDL, 14.3 nm), large (L-HDL, 12.1 nm), medium (M-HDL, 10.9 nm) and small HDL particles (S-HDL, 8.7 nm).^9,17 Independent verification for the robust NMR resolution with respect to the number of lipoprotein subclasses was published by Mihaleva and co-workers with an in-depth handling of the statistical grounds.¹⁸ Particle, triglyceride, phospholipid, cholesteryl ester and free cholesterol concentrations are quantified for all 14 subclasses, allowing also calculation of the relative lipid contents (i.e., lipid composition) for each lipoprotein subclass. The platform also provides all key traditional lipid measures (e.g., total triglycerides, total cholesterol and HDL cholesterol) as well as apolipoprotein B and A-I concentrations. This NMR metabolomics platform has been widely used in epidemiology and genetic studies over the last 10 years^9–11,17 and the general methodological issues have been published and discussed previously.^8,17,19

Population Cohorts

The Northern Finland Birth Cohort 1966 (NFBC66) with data for 5,651 participants (at 46 years of age) were studied as the primary cohort and the NFBC86 with data for 5,605 participants (at 16 years of age) as a replication cohort. More details on the NFBCs can be found in the Supplementary Note. The selection or the traits of the cohorts are not consequential in this study focusing on overall lipoprotein subclass particle characteristics and associations as the existing literature already affirms them highly coherent in and between various large-scale studies.^{9,10,12,13,17,20–24}

Statistical analyses and concepts

The lipoprotein subclass information can be partitioned into three key categories of variables: 1) circulating particle concentrations (the particle numbers are within the range of 0.1 nmol/L and 10 µmol/L), 2) circulating lipid concentrations (within the range of 0.1 and 10 mmol/L) and 3) particle lipid compositions as the percentage of a certain lipid class of total lipids (mol%) per a subclass particle. Apolipoprotein B is the key protein component in VLDL, IDL and LDL particles and they are often called apolipoprotein B-containing particles. HDL particles do not contain apolipoprotein B but are abundant in apolipoprotein A-I. All lipoprotein particles contain also other apolipoprotein molecules, but they cannot be quantified by NMR.²⁵ Spearman’s rank correlations (adjusted for sex) were used in all correlation analyses in this work. Twenty-four principal components explained >99% of variation in the 174 lipoprotein measures (98 concentrations and 70 compositions for the 14 lipoprotein subclasses, 4 traditional lipid measures and apolipoprotein A-I and B). A multiple comparison Bonferroni-corrected P-value threshold of 0.002 (i.e., 0.05/24) was thus used to denote evidence in favour of an association.²⁶ All statistical analyses were performed in the R statistical platform (version 3.6.2).

Characteristics of lipoprotein subclass particles and their concentration attributes

Figure 1. illustrates the 14 lipoprotein subclasses and their relative lipid content (see Figure S1 for replication in the NFBC86). The compositional data are also visualised in the upper part of Figure 2 in comparison to the concentration data (identical data are shown for the NFBC86 in Figure S2). The VLDL subclasses are the most triglyceride-enriched with variation from 69% to 17% of total lipids from XXL-VLDL to XS-VLDL. The IDL and LDL particles are all rich in cholesteryl esters (around 50%) as well as free cholesterol (around 20%). All HDL particles are enriched in phospholipids (around 50%) and very poor in triglycerides.

• Download figure
• Open in new tab

Figure 1

The relative lipid compositions of the 14 lipoprotein subclasses.The NMR platform resolution is 14 lipoprotein subclasses, defined by their particle size as follows: six VLDL particle categories; XXL-VLDL (with average particle diameter >75 nm), XL-VLDL (64 nm), L-VLDL (53.6 nm), M-VLDL (44.5 nm), S-VLDL (36.8 nm), and XS-VLDL (31.3 nm); IDL (28.6 nm), L-LDL (25.5 nm), M-LDL (23.0 nm), and S-LDL (18.7 nm); and XL-HDL (14.3 nm), L-HDL (12.1 nm), M-HDL (10.9 nm) and S-HDL (8.7 nm).^9,17,19 Note that the size of LDL and HDL particles in the figure is multiplied by 1.5 and 2.0, respectively. The data are mean values for 5,651 participants in NFBC66. VLDL, very-low-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; XXL, extremely large; XL, very large; L, large; M, medium; S, small; XS, very small; TG, triglycerides; PL, phospholipids; CE, cholesteryl esters; FC, free cholesterol.

• Download figure
• Open in new tab

Figure 2

The circulatory and compositional characteristics of lipoprotein subclasses.The lipid distribution along the lipoprotein subclasses illustrates how a certain lipid class is distributed in the blood stream among all the lipoprotein subclasses (i.e., the sum of all percentages in each inset is 100%). The composition of lipoprotein subclasses depicts what are the relative lipid contents in each subclass particle category (i.e., the sum of the percentages of all the lipid classes for each subclass is 100%). The data are from the NFBC66 including 5,651 participants; each box plot shows the median within the interquartile range (IQR) and the minimum (Q1-1.5*IQR) and maximum (Q3 + 1.5*IQR) values with potential outliers. The abbreviations are as explained in the caption for Figure 1.

Over 50% of circulating triglycerides are transported in VLDL particles, some 20% in IDL and LDL, and less than 20% in HDL particles (lower part of Figure 2 and S2). Roughly 50% of circulating cholesterol (both free and esterified) travels in IDL and LDL particles and some 20-30% in HDL particles. Around 50% of lipoprotein phospholipids in the circulation are in HDL particles. The size-dependent opposite compositional behaviour of triglycerides and cholesteryl esters in the apolipoprotein B-containing subclass particles is pronounced.

The circulating subclass lipid concentrations depend on both, the lipid composition of a subclass particle and the concentration (i.e., the number) of those particles in the blood stream. The distributions for subclass particle concentrations are shown in Figure 3 (and in Figure S3 for the NFBC86). The HDL particles are by far the most abundant with concentrations in a micromolar range, the IDL and LDL particles being at the range of 0.1-0.3 micromolar and the largest VLDL particles at the range of 0.1 – 10 nanomolar. Thus, on average, there are some 60,000 S-HDL and 1,500 IDL particles per one XXL-VLDL particle in the circulation; 92% of all lipoprotein particles are HDL particles (Figure 3). Therefore, although the volume of an XXL-VLDL particle is approximately 640 times that of an S-HDL particle (and 18 times that of an M-LDL particle), the variation in the particle lipid compositions within a subclass is clearly minor with respect to the variation in corresponding particle concentrations. The circulating particle concentrations are therefore the defining measures for the lipoprotein subclass lipid concentrations. These particle concentrations are log-linearly associated with the subclass particle size as illustrated in Figure 4. This intriguing finding denotes that numbers of circulating lipoprotein particles are fundamentally restricted, both in a relative manner and in absolute concentrations (e.g., the number of VLDL particles must be appropriate for the circulating LDL cholesterol to remain within physiologically relevant limits).

• Download figure
• Open in new tab

Figure 3

The distributions of particle concentrations for each lipoprotein subclass.The data are from the NFBC66 including 5,651 participants. The grey number in the upper-left corner identifies the number of samples for which the particle concentration is zero and in the upper-right corner for how many high concentration values were cut off from the drawn distribution. Note that the concentration scale is nmol for the VLDL, IDL and LDL particles and µmol for the HDL particles. The black vertical lines denote the median concentration values. Various proportions of lipoprotein particles and lipids are shown in the pie charts as mean values for the 5,651 participants in NFBC66. The abbreviations are as explained in the caption for Figure 1.

• Download figure
• Open in new tab

Figure 4

The log-linear relationship between the circulating lipoprotein subclass particle concentration and the particle diameter.The data and abbreviations are as explained in the caption for Figure 1.

The overall outlook on lipoprotein lipid transport, due to large differences in the subclass particle transport volumes, is quite different from the particle view; 65% of all lipoprotein lipids in the circulation are transported in apolipoprotein B-containing particles (Figure 3). On average LDL particles amount to over 70% and the three largest VLDL subclasses only less than a percent of circulating apolipoprotein B-containing particles. The smallest HDL particles constitute over 50% of all circulating HDL particles. The apolipoprotein B-containing particles are most abundant in cholesteryl esters (over 40 mol% of all lipids) and the HDL particles in phospholipids (almost 50 mol%) (Figure 3). The absolute concentrations (mmol/L) for total lipids and the main lipids in all the 14 lipoprotein subclasses are shown in Figure 5 (and in Figure S5 for the NFBC86) together with a summary comparison between apolipoprotein B-containing particles and HDL particles.

• Download figure
• Open in new tab

Figure 5

The absolute circulating lipid concentrations for each lipoprotein subclass and the corresponding summary measures for the apolipoprotein B-containing lipoprotein particles and HDL particles.The data and abbreviations are as explained in the captions for Figure 1 and 2.

Associations between standard lipid and apolipoprotein measures

The standard lipid measures (also based on the NMR platform) behave as expected as illustrated in Figure 6A (and in Figure S6A for the NFBC86 data).¹⁰ The associations between apolipoprotein B and LDL cholesterol, total cholesterol and triglycerides are positive and strong. The negative association between HDL cholesterol and triglycerides is compelling. Apolipoprotein A-I is strongly positively associated with HDL cholesterol. Also, as expected, associations between apolipoprotein A-I and HDL particle concentrations and apolipoprotein B and the corresponding particle concentrations are strong (Figure S7). On the other hand, associations between apolipoprotein A-I and B concentrations (g/L) as well as between HDL particle and apolipoprotein B-containing lipoprotein particle concentrations (mol/L) are very weak. This is explained by negative associations between apolipoprotein B and large and medium HDL particles and a counterbalancing effect due to a positive association between apolipoprotein B and the smallest HDL particles (Figure S8).

• Download figure
• Open in new tab

Figure 6

The associations between traditional lipoprotein lipid measures (A), between traditional lipoprotein lipid measures and lipoprotein subclass particle and triglyceride concentrations (B), between traditional lipoprotein lipid measures and lipoprotein subclass lipid composition for triglycerides and cholesteryl esters (C), and between lipoprotein subclass particle and triglyceride concentrations and lipoprotein subclass lipid composition for triglycerides and cholesteryl esters (D). The colour key refers to Spearman’s rank correlation coefficients the NFBC66 including 5,651 participants (adjusted for sex). Twenty-three principal components explained >99% of variation in the 174 lipoprotein measures (98 concentrations and 70 compositions for the lipoprotein subclasses, 4 traditional lipid measures and apolipoprotein A-I and B). Thus, a P-value threshold of 0.002 (i.e., 0.05/24) was used to denote evidence in favour of an association (marked *in the maps). The %-sign refers to the compositional measures (i.e., the percentage of a lipid class concentration of the total lipid concentration in a particular lipoprotein subclass). Serum-TG, total circulating triglyceride concentration; Serum-C, total circulating cholesterol concentration; LDL-C, LDL cholesterol; APOB, apolipoprotein B; HDL-C, HDL cholesterol; APOA-I, apolipoprotein A-I. Other abbreviations are as explained in the caption for Figure 1.

Associations between standard lipid measures and lipoprotein subclass concentrations

The associations between the 14 lipoprotein subclass measures and the standard lipid measures are all logical (Figure 6B and S6B). The associations of apolipoprotein B with all VLDL, IDL and LDL subclass concentration measures are positive and strong. VLDL subclass concentration measures associate positively with serum triglycerides and negatively with HDL cholesterol. Associations between LDL cholesterol and IDL and LDL subclass concentration measures are positive and strong. The associations with HDL subclass measures are heterogeneous, however, HDL cholesterol and apolipoprotein A-I correlate positively with all HDL subclass particle concentrations.

Associations between standard lipid measures and lipoprotein subclass compositions

The triglyceride composition of all lipoprotein subclasses is positively associated with circulating triglyceride concentration, except in the case of XXL-VLDL (Figure 6C and S6C). The cholesteryl ester composition of all LDL subclass particles is strongly positively associated with circulating total and LDL cholesterol as well as apolipoprotein B concentrations. Circulating HDL cholesterol and apolipoprotein A-I concentrations are negatively associated with the triglyceride composition of all VLDL and IDL particles, positively associated with the cholesteryl ester composition of S-, M, and L-HDL particles, but the association is negative for XL-HDL particles.

Associations between lipoprotein subclass concentrations and compositions

An opposite compositional behaviour is typical between triglycerides and cholesteryl esters (Figure 6D and S6D). For example, high circulating particle and triglyceride concentrations for apolipoprotein B-containing lipoprotein particles associate with triglyceride enrichment and diminished composition of cholesteryl esters in M- and L-HDL particles. Similar strong relationships exist between the concentrations as well as triglyceride and cholesteryl ester compositions of XS-, S-, M-, L-, and XL-VLDL particles. The triglyceride composition of all HDL subclass particles is consistently positively associated with all apolipoprotein B-containing lipoprotein particle and triglyceride concentrations. The circulating concentrations of M-, L-, and XL-HDL particles are negatively associated with their triglyceride compositions.

Associations between lipoprotein subclass concentrations

The associations between all the apolipoprotein B-containing lipoprotein subclass concentration measures form a coherent pattern and reflect the continuous metabolism from VLDL to LDL particles in the blood stream (Figure 7A and S9A). Positive associations between adjacent subclasses are high and there is a general trend of weakening positive associations along the line of the metabolic direction from large VLDL to LDL particles. The association pattern appears different for XL- and L-HDL in comparison to M- and S-HDL subclasses. The subclass particle concentrations of large and medium HDL subclasses associate negatively with all VLDL subclasses but the associations for the smallest HDL subclass are in the opposite direction. Similarly, S-HDL particle concentrations are negatively associated with those of XL- and L-HDL. The circulating triglyceride concentration in every apolipoprotein B-containing subclass associates consistently positively with the corresponding measure in both M- and S-HDL.

• Download figure
• Open in new tab

Figure 7

The associations between lipoprotein subclass particle and triglyceride concentrations (A) and between lipoprotein subclass lipid composition for triglycerides and cholesteryl esters (B).The data and abbreviations are as explained in the caption for Figure 6.

Associations between lipoprotein subclass compositions

The associations between lipoprotein subclass lipid compositions (Figure 7B and S9B) are generally a lot weaker and more heterogeneous than the corresponding associations between the concentration measures (Figure 7A and S9A). A global feature is that the triglyceride compositions of almost all lipoprotein subclass particles are strongly positively associated. These compositional triglyceride associations are strong in each major fraction of particles, i.e., within VLDL, IDL and LDL as well as HDL, but also mostly between these fractions with only a few triglyceride compositions in the largest VLDL subclasses showing either very weak or negative associations. Overall triglyceride and cholesteryl ester compositions tend to associate negatively, particularly within the major fractions of particles.

A correlation heatmap between all the lipoprotein subclass concentration, composition and standard lipid measures as well as apolipoprotein B and A-I are shown in Figure S10 for the NFBC66 and in Figure S11 for the NFBC86. The numerical data for these correlations are available in Supplementary Table 1 and Supplementary Table 2, respectively. Figure S12 illustrates the comprehensive lipoprotein subclass data and the intertwined correlation structure in a metabolic network model.

Key results and the fundamental characteristics of lipoprotein subclass particles and metabolism are highlighted in a summary Figure 8.

• Download figure
• Open in new tab

Figure 8

A summary figure encapsulating the key characteristics, associations and metabolic features of the 14 lipoprotein subclasses quantified with the NMR spectroscopy platform.^9,17,19 The position of the individual lipoprotein subclass particles on the NMR size-resolution axis aims to picture the methodological resolution difference for large and small lipoprotein particles.^6,16

Biomolecular and metabolic constraints regarding lipoprotein subclasses

It has been shown earlier that the circulating lipid concentrations as well as the relative lipid compositions for the lipoprotein subclasses with this methodology are very well concordant with those from density-based ultracentrifugation analyses,^4,27 clinical chemistry¹⁰ and high-performance liquid chromatography.¹⁷ The compositional changes in relative to triglycerides and cholesteryl esters are an intrinsic indication of the metabolic continuum in the VLDL-LDL metabolic cascade in the circulation.^13,28,29 As far as we are aware, the log-linear relationship between circulating lipoprotein subclass particle concentrations and the particle size has not been indicated before. The scale of difference in the subclass particle numbers is huge, e.g., 60,000 S-HDL particles per one circulating XXL-VLDL particle (Figure 8). On average, over 90% of all circulating lipoprotein particles are HDL particles. Even though the particle volumes also differ considerably for different lipoprotein subclasses, the scale is far from the scale in the particle concentrations: the volume of an XXL-VLDL particle is approximately 640 times that of an S-HDL particle. Therefore, the subclass particle concentrations are the main determinants of circulating lipoprotein subclass lipid concentrations and the variation in their lipid compositions is only a minor contributor. However, the view for circulating lipids is quite different from that of the individual particles: only 35% of all lipoprotein lipids are transported in HDL particles.

The key metabolic role of lipoprotein subclass particle concentrations is not unexpected. Within the particles, the size and structural molecular constraints fundamentally define how many non-polar and polar lipid molecules can be accommodated both in the core and surface, respectively. Although the core and surface regions are not rigid, the spherical shape with an oriented monolayer poses strong biophysical constraints within the small number of key lipid classes – triglycerides, phospholipids, free and esterified cholesterol – to be integrated into the particles.^4,5,16 Thus, functional metabolic issues, e.g., an increasing dietary fat load, must be solved by increasing the number of chylomicron (exogenously) and VLDL (endogenously) particles to transport the triglycerides; the structural modifications at the particle level would not be able to accommodate changes at that scale due to the biomolecular constraints. This does not mean, however, that the concentration issues would not affect the compositional characteristics (please see below in relation to triglycerides), but it is crucial to appreciate the largely different scale of achievable concentration changes and compositional modifications.

The log-linear relationship between lipoprotein subclass particle concentrations and the particle size suggest an existence of also fundamental metabolic constraints. This means that not only typical particle and lipid concentration ranges are elemental for humans, but also only certain relative lipoprotein subclass particle concentrations are possible in human lipoprotein metabolism. We are not aware of previous discussion directly in relation to this, but we find it implicit in the lipoprotein literature and, for example, via the traditional clinical definitions of abnormalities in lipoprotein metabolism and their drug treatment.³⁰ The large-scale data and the high resolution with respect to lipoprotein subclasses only amplifies and clarifies this issue. It is rather logical that a certain (even very high) load of nutritional fats (i.e., triglycerides) would lead to a corresponding amount of transport particles, exogenously in the form of gut-derived chylomicron/apoB48-containing particles and endogenously via apoB100-containing VLDL particles.²⁸ What can metabolically come out of the apolipoprotein B48/B100-containing lipoprotein cascades in the form of remnant, IDL and LDL subclass particles in the circulation, must be in a direct relationship with the secreted amount of chylomicron and/or VLDL particles. The amount of HDL particles partly couples with this cascade though also other sources and metabolic processes for HDL particles and their variation exist.³¹ Notably apolipoprotein B and A-I concentrations (or apolipoprotein B-containing lipoprotein and HDL particle concentrations) only associate very weakly per se. This is explained by the opposite associations between apolipoprotein B and the larger/medium versus the smallest HDL particles. Altogether it is likely that these metabolic constraints are just simple reflections of normal metabolic pathways on how the human body handles triglycerides, cholesteryl esters and other dietary lipids. A key corollary, however, is that when evaluating a risk related to a lipoprotein subclass, it would only be relevant to estimate it within the physiologically realistic concentration area.^21–24

Standard lipids, lipoprotein subclasses and their lipid composition

The associations between the standard lipid measures and the subclass concentration measures are intuitive based on how the subclass particle categories are included in the standard lipid measures. For example, HDL cholesterol is the cholesterol carried in all the HDL subclass particles in the circulation and the triglyceride concentration refers to the sum of triglycerides in all the lipoprotein subclass particles. In the case of LDL cholesterol, the situation is clear within the NMR analysis, i.e., it represents the sum of cholesterol in all LDL subclass particles. Thus, the LDL cholesterol based on the NMR platform is size-specific and does not include cholesterol in any other particles. Generally, however, “LDL” as a concept is far from clear since multiple “LDL” cholesterol assays exist based on remarkably varying methodologies, leading to between-assay heterogeneity in the values of “LDL” cholesterol. The assay-dependent ambiguity can lead to either under-or over-estimation of the true (size-specific) LDL cholesterol. We have recently discussed these issues and their potential implications in detail.¹⁴ The size-specific accurate definition of LDL and other lipoprotein subclasses is a definite virtue of the NMR-based lipoprotein analytics.

The overall association pattern for the lipoprotein subclass concentration measures is structured and characterised by strong correlations between adjacent apolipoprotein B-containing lipoprotein subclasses with clearly diminishing associations along the metabolic continuum from VLDL to LDL particles. On the contrary, the association pattern for the lipoprotein subclass composition measures is assorted and lacks pronounced patterns. Overall triglyceride and cholesteryl ester compositions tend to associate negatively, particularly within the major lipoprotein fractions VLDL, IDL and LDL, and HDL. A consolidated interpretation of all the associations between the concentration and composition measures is the consistent behaviour of triglycerides. High circulating triglyceride concentrations are reflected by high concentrations of triglyceride-enriched VLDL particles that appear to cause a metabolic spillover effect and result in coherently triglyceride-enriched particles in all lipoprotein subclasses. The smallest HDL subclass behaves similarly to apolipoprotein B-containing subclasses regarding various associations, in contradiction to the other HDL subclasses.

Large-scale epidemiology in relation to lipoprotein subclass data

This particular NMR platform has been applied in a few large-scale prospective cardiovascular outcome studies with the focus on lipoprotein subclass concentrations.^21–24,32 The lipoprotein subclass risk profile for cardiovascular events in a European population²¹ and for incident myocardial infarction in a Chinese population²² appears highly concordant. The subclass risk profile is similar between incident myocardial infarction and ischemic stroke, but differs considerably for intracerebral haemorrhage for which none of the lipoprotein subclasses appears as a risk factor.²² There are also apparent differences in how the lipoprotein subclasses associate with peripheral and coronary artery disease, the associations being weaker for the former.²⁴ Applications in other areas, as reviewed by Würtz et al. in 2017,¹⁰ have also almost entirely utilised only lipoprotein subclass concentration data.¹⁰ Most recent large-scale applications involve studies on, e.g., oral glucose tolerance test,³³ healthy diets and risk of cardiovascular disease,³⁴ and exome sequencing for rare variants in cardiometabolic traits.³⁵

Large-scale epidemiology in relation to compositional data on lipoprotein subclasses

Only a few large-scale epidemiological studies have exploited the compositional lipoprotein subclass data from this NMR platform or in general. Laakso and co-workers studied lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance in a population-based study of over 9,000 Finnish men.²⁰ Concomitantly to increased serum concentrations of essentially all apolipoprotein B-containing lipoprotein particles as well as the smallest HDL particles, hyperglycaemia and insulin resistance were associated with triglyceride-enrichment in various subclass particles, although these differences were related more to hypertriglyceridaemia than to hyperglycaemia.²⁰ Barrios et al.³⁶ noted that in both diabetic and non-diabetic individuals the triglyceride composition of various apolipoprotein B-containing and some HDL particles were rather coherently inversely associated with kidney function and microvascular complications of diabetes. A recent study examined observational associations of all lipoprotein subclass measures with risk of incident CHD in three population-based cohorts totalling 616 incident cases and 13,564 controls during 8-year follow-up.¹³ This study was the first large-scale study to assess the independent role of lipoprotein subclass composition in CHD risk assessment with the finding that a higher triglyceride composition within HDL subclasses was associated with higher risk of CHD, independently of total cholesterol and triglycerides. The largest hazard ratio for the triglyceride-enrichment in medium HDL subclass particles was of a similar magnitude as that for LDL cholesterol and apolipoprotein B, i.e., around 1.3. However, the findings were interpreted to reflect the combined effects of circulating HDL and apolipoprotein B-containing particles, maybe in connection to CETP function and the circulating amount of total triglycerides, not an intrinsic indication of an independent role of HDL particle lipid composition in CHD.¹³

Drug-target Mendelian randomization

The lipoprotein subclass data have recently been actively utilised in drug-target Mendelian randomization analyses.^{12,13,15,37,38} In these studies specific genetic instruments are used as a proxy for the pharmacological on-target effects of proteins to understand and quantify the involvement of a protein in disease.^37–39 The detailed size-resolution provided by the NMR-based lipoprotein data has been advantageous in the detailed appreciation of the intricate details and differences in various cholesterol lowering drugs.^12,15,37 The comparison between the results from actual randomised controlled drug trials and the drug-target Mendelian randomization is compelling, as recently demonstrated in a prospective pravastatin trial together with comparisons to the metabolic effects of genetic inhibition of HMG-CoA reductase (statins) and proprotein convertase subtilisin/kexin type 9 (PCSK9).¹² A drug-target Mendelian randomization study on CETP inhibition revealed that conventional composite lipid assays (e.g., “LDL cholesterol”)¹⁴ may mask important heterogeneous effects on lipoprotein profiles.^13,40 The differences between the observed drug effects on traditional “LDL cholesterol” and, both analytically and metabolically, more specific apolipoprotein B-containing lipoprotein subclasses are calling attention to the need for metabolic precision in the measurements of lipoprotein data and in assessing the role of lipoprotein metabolism in cardiovascular disease in relation to existing and novel lipid-altering therapies. A particularly problematic issue would be to use a nonspecific marker of lipids to derive an expected effect of a drug with risk of disease.^13,14 The combination of NMR-based lipoprotein subclass data with drug-target Mendelian randomization analyses has shown a great synergy for drug development in the current era of biobanks and big data. However, it should be kept in mind that the use of drug-target Mendelian randomization analysis can principally provide information only on pharmacological on-target effects (of a class of drugs) and does not allow for assessing potential off-target effects (of individual drugs).⁴¹

Lipoprotein subclass measures as risk factors

The high size-resolution offered by the NMR-based lipoprotein profiling has resulted in a detailed understanding of how the various stages and remnant particles in the apolipoprotein B-containing lipoprotein cascade relate to cardiometabolic issues and outcomes.^{10,21,22,29,42} However, from the predictive risk factor perspective the additional information provided by the lipoprotein subclass particle concentrations in common cardiovascular disease outcomes appears inconsequential, particularly keeping in mind the current recognition of the key role of apolipoprotein B in the development of atherosclerosis and CHD.^{13,21,43–45} The potential role of lipoprotein particle compositions (as independent of concentrations) has occasionally been discussed in the literature since the advent of sequential preparative ultracentrifugation for lipoprotein analytics but the tediousness and cost of the process have precluded large-scale studies.^2,13 The clinically most utilised NMR-based lipoprotein analytics unfortunately does not provide compositional lipoprotein subclass data.^7,46 Thus, the first large-scale study on the independent role of lipoprotein particle compositions on CHD was published only very recently and based on the NMR methodology on focus here.¹³ However, as discussed above, the most pronounced findings regarding the increased risk in relation to triglyceride-enrichment of HDL particles, might just be a reflection of high circulating triglycerides and not an intrinsic indication of an independent role of HDL particle lipid composition in CHD.¹³ Nonetheless, in type 1 diabetes triglyceride-cholesterol imbalance has been found as a general lipoprotein characteristic indicating high vascular disease risk.⁴⁷